Probable neuroimmunological link between Toxoplasma and cytomegalovirus infections and personality changes in the human host
Jazyk angličtina Země Velká Británie, Anglie Médium electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
16000166
PubMed Central
PMC1187888
DOI
10.1186/1471-2334-5-54
PII: 1471-2334-5-54
Knihovny.cz E-zdroje
- MeSH
- cytomegalovirové infekce komplikace imunologie psychologie MeSH
- dospělí MeSH
- lidé MeSH
- osobnost fyziologie MeSH
- pátrací chování fyziologie MeSH
- protilátky protozoální krev MeSH
- protilátky virové krev MeSH
- studie případů a kontrol MeSH
- toxoplazmóza komplikace imunologie psychologie MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- protilátky protozoální MeSH
- protilátky virové MeSH
BACKGROUND: Recently, a negative association between Toxoplasma-infection and novelty seeking was reported. The authors suggested that changes of personality trait were caused by manipulation activity of the parasite, aimed at increasing the probability of transmission of the parasite from an intermediate to a definitive host. They also suggested that low novelty seeking indicated an increased level of the neurotransmitter dopamine in the brain of infected subjects, a phenomenon already observed in experimentally infected rodents. However, the changes in personality can also be just a byproduct of any neurotropic infection. Moreover, the association between a personality trait and the toxoplasmosis can even be caused by an independent correlation of both the probability of Toxoplasma-infection and the personality trait with the third factor, namely with the size of living place of a subject. To test these two alternative hypotheses, we studied the influence of another neurotropic pathogen, the cytomegalovirus, on the personality of infected subjects, and reanalyzed the original data after the effect of the potential confounder, the size of living place, was controlled. METHODS: In the case-control study, 533 conscripts were tested for toxoplasmosis and presence of anti-cytomegalovirus antibodies and their novelty seeking was examined with Cloninger's TCI questionnaire. Possible association between the two infections and TCI dimensions was analyzed. RESULTS: The decrease of novelty seeking is associated also with cytomegalovirus infection. After the size of living place was controlled, the effect of toxoplasmosis on novelty seeking increased. Significant difference in novelty seeking was observed only in the largest city, Prague. CONCLUSION: Toxoplasma and cytomegalovirus probably induce a decrease of novelty seeking. As the cytomegalovirus spreads in population by direct contact (not by predation as with Toxoplasma), the observed changes are the byproduct of brain infections rather than the result of manipulation activity of a parasite. Four independent lines of indirect evidence, namely direct measurement of neurotransmitter concentration in mice, the nature of behavioral changes in rodents, the nature of personality changes in humans, and the observed association between schizophrenia and toxoplasmosis, suggest that the changes of dopamine concentration in brain could play a role in behavioral changes of infected hosts.
Zobrazit více v PubMed
Hutchison WM, Aitken PP, Wells BWP. Chronic Toxoplasma infections and motor performance in the mouse. Ann Trop Med Parasitol. 1980;74:505–510. PubMed
Witting PA. Learning capacity and memory of normal and Toxoplasma-infected laboratory rats and mice. Z Parasitenkd. 1979;61:29–51. doi: 10.1007/BF00927085. PubMed DOI
Hutchison WM, Aitken PP, Wells BWP. Chronic Toxoplasma infection and familiarity-novelty discrimination in the mouse. Ann Trop Med Parasitol. 1980;74:145–150. PubMed
Hay J, Hutchison WM, Aitken PP, Graham DI. The effect of congenital and adult-acquired Toxoplasma infections on activity and responsiveness to novel stimulation in mice. Ann Trop Med Parasitol. 1983;77:483–495. PubMed
Hay J, Aitken PP, Hair DM, Hutchison WM, Graham DI. The effect of congenital Toxoplasma infection on mouse activity and relative preference for exposed areas over a series of trials. Ann Trop Med Parasitol. 1984;78:611–618. PubMed
Hay J, Aitken PP, Arnott MA. The influence of Toxoplasma infection on the spontaneous running activity of mice. Z Parasitenkd. 1985;71:459–462. doi: 10.1007/BF00928348. PubMed DOI
Hay J, Hutchison WM, Aitken PP. Congenital Toxoplasma infection and response to novelty in mice. Ann Trop Med Parasitol. 1983;77:437–439. PubMed
Hay J, Aitken PP, Graham DI. Toxoplasma infection and response to novelty in mice. Z Parasitenkd. 1984;70:575–588. doi: 10.1007/BF00926588. PubMed DOI
Hrda S, Votypka J, Kodym P, Flegr J. Transient nature of Toxoplasma gondii-induced behavioral changes in mice. J Parasitol. 2000;86:657–663. PubMed
Webster JP. The effect of Toxoplasma gondii and other parasites on activity levels in wild and hybrid Rattus norvegicus. Parasitology. 1994;109:583–589. PubMed
Webster JP, Brunton CFA, Macdonald DW. Effect of Toxoplasma gondii upon neophobic behaviour in wild brown rats, Rattus norvegicus. Parasitology. 1994;109:37–43. PubMed
Berdoy M, Webster JP, Macdonald DW. Fatal attraction in rats infected with Toxoplasma gondii. Proc Biol Sci. 2000;267:1591–1594. doi: 10.1098/rspb.2000.1182. PubMed DOI PMC
Havlicek J, Gasova Z, Smith AP, Zvara K, Flegr J. Decrease of psychomotor performance in subjects with latent 'asymptomatic' toxoplasmosis. Parasitology. 2001;122:515–520. doi: 10.1017/S0031182001007624. PubMed DOI
Flegr J, Havlicek J, Kodym P, Maly M, Smahel Z. Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-controlstudy. BMC Infect Dis. 2002;2:art–11. doi: 10.1186/1471-2334-2-11. PubMed DOI PMC
Flegr J, Hrdy I. Influence of chronic toxoplasmosis on some human personality factors. Folia Parasitol. 1994;41:122–126. PubMed
Flegr J, Zitkova S, Kodym P, Frynta D. Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Parasitology. 1996;113:49–54. PubMed
Flegr J, Kodym P, Tolarova V. Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biol Psychol. 2000;53:57–68. doi: 10.1016/S0301-0511(00)00034-X. PubMed DOI
Flegr J, Preiss M, Klose J, Havlicek J, Vitakova M, Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis? Biol Psychol. 2003;63:253–268. doi: 10.1016/S0301-0511(03)00075-9. PubMed DOI
Stibbs HH. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol. 1985;79:153–157. PubMed
Minto A, Roberts FJ. The psychiatric complications of toxoplasmosis. Lancet. 1959:1180–1182. doi: 10.1016/S0140-6736(59)91187-0. PubMed DOI
Robertson JS. Toxoplasma skin- and dye-test surveys of severely subnormal patients in Lincolnshire. J Hyg Camb. 1965;63:89–98. PubMed PMC
Kramer W. Frontiers of neurological diagnosis in acquired toxoplasmosis. Psych Neurol Neurochir. 1966;69:43–64. PubMed
Ladee GA, Scholten JM, Meyes FEP. Diagnostic problems in psychiatry with regard to acquired toxoplasmosis. Psych Neurol Neurochir. 1966;69:65–82. PubMed
Yolken RH, Bachmann S, Ruslanova I. Antibodies to Toxoplasma gondii in individuals with first- episode schizophrenia. Clin Infect Dis. 2001;32:1247–1247. doi: 10.1086/319221. PubMed DOI
Torrey EF, Yolken RH. Toxoplasma gondii and schizophrenia. Emerg Infect Dis. 2003;9:1375–1380. PubMed PMC
Torrey EF, Yolken RH. Could schizophrenia be a viral zoonosis transmitted from house cats. Schizophrenia Bull. 1995;21:167–171. doi: 10.1016/0920-9964(95)00042-K. PubMed DOI
Torrey EF, Rawlings R, Yolken RH. The antecedents of psychoses: a case-control study of selected risk factors. Schizoph Res. 2000;46:17–23. doi: 10.1016/S0920-9964(99)00237-6. PubMed DOI
Torrey EF, Yolken RH. The schizophrenia-rheumatoid arthritis connection: Infectious, immune, or both? Brain Beh Immun. 2002;15:401–410. doi: 10.1006/brbi.2001.0649. PubMed DOI
Cloninger CR. The genetics and psychobiology of the seven-factor model of personality. In: Silk KR, editor. Biology of personality disorders. Washington,DC, American Psychiatric Press, Inc.; 1998. pp. 63–92.
Wiesbeck GA, Mauerer C, Thome J, Jakob F, Boening J. Neuroendocrine support for a relationship between "novelty seeking" and dopaminergic function in alcohol-dependent men. Psychoneuroendocrinology. 1995;20:755–761. doi: 10.1016/0306-4530(95)00014-3. PubMed DOI
Ruegg RG, Gilmore J, Ekstrom RD, Corrigan M, Knight B, Tancer M, Leatherman ME, Carson SW, Golden RN. Clomipramine challenge responses covary with Tridimensional Personality Questionnaire scores in healthy subjects. Biol Psychiatry. 1997;42:1123–1129. doi: 10.1016/S0006-3223(97)00009-7. PubMed DOI
Gerra G, Zaimovic A, Timpano M, Zambelli U, Begarani M, Marzocchi GF, Ferri M, Delsignore R, Brambilla F. Neuroendocrine correlates of temperament traits in abstinent opiate addicts. Journal of Substance Abuse. 2000;11:337–354. doi: 10.1016/S0899-3289(00)00031-6. PubMed DOI
Hansenne M, Pinto E, Pitchot W, Reggers J, Scantamburlo G, Moor M, Ansseau M. Further evidence on the relationship between dopamine and novelty seeking: a neuroendocrine study. Person Indiv Differ. 2002;33:967–977. doi: 10.1016/S0191-8869(01)00205-7. DOI
Kodym P, Malý M, Svandová E, Lekatková H, Badoutová M, Vlková J, Benes C, Zástera M. Toxoplasma in the Czech Republic 1923-1999: first case to widespread outbreak. Int J Parasitol. 2000;30:11–18.
Britt WJ. Human cytomegalovirus overview: The virus and its pathogenic mechanisms. Baillieres Clin Infect Dis. 1996;3:307–325.
Jones J, Lopez A, Wilson M. Congenital toxoplasmosis. Am Fam Phys. 2003;67:2131–2138. PubMed
Arribas JR, Storch GA, Clifford DB, Tselis AC. Cytomegalovirus encephalitis. Ann Intern Med. 1996;125:577–587. PubMed
Israelski DM, Chmiel JS, Poggensee L, Phair JP, Remington JS. Prevalence of Toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitis. J Acquired Immune Defic Syndr. 1993;6:414–418. PubMed
Da Cunha S, Ferreira E, Ramos I, Martins R, De FL, Borges JL, Corte-Real R, Mota A, Melico-Silvestre A, Furtado AL. Cerebral toxoplasmosis after renal transplantation. Case report and review. Acta Med Port. 1994;7:S61–S66. PubMed
Cinque P, Marenzi R, Ceresa D. Cytomegalovirus infections of the nervous system. Intervirology. 1997;40:85–97. PubMed
Arendt G, von Giesen HJ, Hefter H, Neuen-Jacob E, Roick H, Jablonowski H. Long-term course and outcome in AIDS patients with cerebral toxoplasmosis. Acta Neurol Scand. 1999;100:178–184. PubMed
Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD. The temperament and character inventory (TCI): a guide to its development and use. Center for Psychobiology of Personality, St.Louis Missouri, Washington University Press; 1994.
Kožený J, Tisanská L. Formální vlastnosti dotazníku TCI testované na datech adolescentù. CS Psychol. 1998;42:75–83.
Preiss M, Klose J. Diagnostika poruch osobnosti pomocí teorie C R Cloningera. Psychiatrie. 2003;4:226–231.
Otis AS. In: Otis Quick-Scoring Mental Ability Test, New Edition, editor. Tarrytown-on-Hudson, NY, Word Book Co; 1954.
Pokorny J, Fruhbauer Z, Polednakova S, Sykora J, Zastera M, Fialova D. Stanoveni antitoxoplasmickych protilatek IgG netodou ELISA (Assessment of antitoxoplasmatic IgG antibodies with the ELISA method) Cs Epidem. 1989;38:355–361. PubMed
Warren J, Sabin AB. The complement fixation reaction in toxoplasmic infection. Proc Soc Exp Biol Med. 1942;51:11–16.
Rothschild DM, O'Grady M, Wecker L. Neonatal cytomegalovirus exposure decreases prepulse inhibition in adult rats: implications for schizophrenia. J Neurosci Res. 1999;57:429–434. doi: 10.1002/(SICI)1097-4547(19990815)57:4<429::AID-JNR2>3.0.CO;2-D. PubMed DOI
O'Kusky JR, Boyes BE, Walker DG, McGeer EG. Cytomegalovirus infection of the developing brain alters catecholamine and indoleamine metabolism. Brain Res. 1991;559:322–330. doi: 10.1016/0006-8993(91)90019-R. PubMed DOI
Dunn AJ. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. Life Sci. 1988;43:429–435. doi: 10.1016/0024-3205(88)90522-X. PubMed DOI
Kabiersch A, del Rey A, Honegger CG, Besedovsky HO. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav Immun. 1988;2:267–274. doi: 10.1016/0889-1591(88)90028-1. PubMed DOI
Araujo DM, Lapchak PA, Collier B, Quirion R. Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res. 1989;498:257–266. doi: 10.1016/0006-8993(89)91104-9. PubMed DOI
Zalcman S, Murray L, Dyck DG, Greenberg AH, Nance DM. Interleukin-2 and -6 induce behavioral-activating effects in mice. Brain Res. 1998;811:111–121. doi: 10.1016/S0006-8993(98)00904-4. PubMed DOI
Alonso R, Chaudieu I, Diorio J, Krishnamurthy A, Quirion R, Boksa P. Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells. J Neurochem. 1993;61:1284–1290. PubMed
Petitto JM, McCarthy DB, Rinker CM, Huang Z, Getty T. Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. J Neuroimmunol. 1997;73:183–190. doi: 10.1016/S0165-5728(96)00196-8. PubMed DOI
De Sarro GB, Masuda Y, Ascioti C, Audino MG, Nistico G. Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone. Neuropharmacology. 1990;29:167–179. doi: 10.1016/0028-3908(90)90057-X. PubMed DOI
Denicoff KD, Rubinow DR, Papa MZ, Simpson C, Seipp CA, Lotze MT, Chang AE, Rosenstein D, Rosenberg SA. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med. 1987;107:293–300. PubMed
West WH, Tauer KW, Yannelli JR, Marshall GD, Orr DW, Thurman GB, Oldham RK. Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. New Engl J Med. 1987;316:898–905. PubMed
Conley FK, Jenkins KA. Immunohistological study of the anatomic relationship of Toxoplasma antigens to the inflammatory response in the brains of mice chronically infected with Toxoplasma gondii. Infect Immun. 1981;31:1184–1192. PubMed PMC
Arsenijevic D, Girardier L, Seydoux J, Chang HR, Dulloo AG. Altered energy balance and cytokine gene expression in a murine model of chronic infection with Toxoplasma gondii. Am J Physiol. 1997;272:908–917. PubMed
Schluter D, Kaefer N, Hof H, Wiestler OD, Deckertschluter M. Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. Am J Pathol. 1997;150:1021–1035. PubMed PMC
Denkers EY, Gazzinelli RT. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev. 1998;11:569–588. PubMed PMC
Cai GF, Radzanowski T, Villegas EN, Kastelein R, Hunter CA. Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii. J Immunol. 2000;165:2619–2627. PubMed
Fischer HG, Reichmann G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol. 2001;166:2717–2726. PubMed
Albrecht P, Torrey EF, Boone E, Hicks JT, Daniel N. Raised cytomegalovirus-antibody level in cerebrospinal fluid of schizophrenic patients. Lancet. 1980;2:769–772. doi: 10.1016/S0140-6736(80)90386-4. PubMed DOI
Yolken RH, Torrey EF. Hypothesis of a viral etiology in bipolar disorder. In: Soares JC and Gershon S, editor. Bipolar disorders Basic mechanisms and therapeutic implications. New York, Marcel Dekker, Inc; 2002. pp. 305–315.
Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 1988;1:179–186. doi: 10.1016/0893-133X(88)90012-7. PubMed DOI
Sawa A, Snyder SH. Schizophrenia: diverse approaches to a complex disease. Science. 2002;296:692–695. doi: 10.1126/science.1070532. PubMed DOI
Abramsky O, Litvin Y. Automimmune response to dopamine-receptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia. Perspect Biol Med. 1978;22:104–114. PubMed
Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH. Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am J Psychiatry. 1993;150:1408–1410. PubMed
McAllister CG, van Kammen DP, Rehn TJ, Miller AL, Gurklis J, Kelley ME, Yao J, Peters JL. Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am J Psychiatry. 1995;152:1291–1297. PubMed
Potential immunomodulatory effects of latent toxoplasmosis in humans
Effects of toxoplasma on human behavior